Home > Signaling Pathways>Metabolism>P450 (e.g. CYP)>Ezutromid (BMN-195, SMTC-1100)
Ezutromid (BMN-195, SMTC-1100)

This product is for research use only, not for human use. We do not sell to patients.

Ezutromid (BMN-195, SMTC-1100)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
250mg$700Check With Us
500mg$1250Check With Us
1g$1875Check With Us

Cat #: V2872 CAS #: 945531-77-1 Purity ≥ 99%

Description: Ezutromid (also known as BMN-195 and SMTC-1100) is a first-in-class, orally bioavailable, small molecule modulator of the utrophin's translation with EC50 of 0.4 uM.

References: Chancellor DR, et al. Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy. J Med Chem. 2011;54(9):3241-3250.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)337.39
Molecular FormulaC19H15NO3S
CAS No.945531-77-1
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: 10 mg/mLr
Water: <1 mg/mLr
Ethanol:
SMILES CodeO=S(C1=CC=C(OC(C2=CC=C3C=CC=CC3=C2)=N4)C4=C1)(CC)=O
SynonymsEzutromid; SMTC1100; SMTC-1100; SMTC 1100; BMN-195; BMN 195; BMN195; VOX-C1100; SMT C-1100; SMT C1100; SMT 1100; SMT-C1100; SMT C1100; SMTC1100; SMT-C-1100; SMT C-1100
ProtocolIn VitroEzutromid induces increased levels of utrophin RNA in human muscle cells. Treatment of human DMD cells with Ezutromid lead to a 2-fold increase in utrophin protein levels at an optimal concentration of 0.3 uM after 3 days of treatment. Ezutromid was safe and well tolerated with plasma concentrations achieved suf cient to cause a 50% increase in concentrations of utrophin in cells. Ezutromid led to a 30% increase in Utrn mRNA level and resulted in a 2.0-fold increase in UTRN protein level.
In VivoNote: You can dissolve the products in phosphate buffered saline (PBS), 0.1% Tween-20, 5% DMSO)
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM2.9639 mL14.8196 mL29.6393 mL59.2786 mL
5mM0.5928 mL2.9639 mL5.9279 mL11.8557 mL
10mM0.2964 mL1.4820 mL2.9639 mL5.9279 mL
20mM0.1482 mL0.7410 mL1.4820 mL2.9639 mL
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.